808 filings
Page 11 of 41
8-K
04co9v rezoz5bo6d7
11 Sep 17
Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent Developments
12:00am
DEFA14A
dhnx0xxa
11 Sep 17
Additional proxy soliciting materials
12:00am
UPLOAD
hmmlm1zfw
6 Sep 17
Letter from SEC
12:00am
8-K
xaiz iyokmj
5 Sep 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
4
mdfaue26 u132akpk
29 Aug 17
PEREGRINE PHARMACEUTICALS / ERIC S SWARTZ ownership change
12:00am
PREC14A
fg48zd4e5 buwv
29 Aug 17
Preliminary proxy with contested solicitation
12:00am
4
mxbddsa40udt7foak
29 Aug 17
PEREGRINE PHARMACEUTICALS / CARLTON M JOHNSON ownership change
12:00am
4
94bqw5oo7dexxx2tj
29 Aug 17
PEREGRINE PHARMACEUTICALS / DAVID POHL ownership change
12:00am
DFAN14A
vaqy4aj70ku4
14 Aug 17
Additional proxy materials by non-management
12:00am
SC 13G/A
42ak rz0pe
14 Aug 17
Peregrine Pharmaceuticals Inc
12:00am
8-K
y05k7l r745
11 Aug 17
Peregrine Announces Measures to Reduce Costs, Facilitate Profitability and Strengthen its Operations
12:00am
DEFA14A
61cuxp1g hh17kb8a6
11 Aug 17
Additional proxy soliciting materials
12:00am
DEFA14A
zh9q4v1kq49wk
31 Jul 17
Additional proxy soliciting materials
12:00am
8-K
hyupub30
25 Jul 17
Other Events
12:00am
DEFA14A
u7pxqv
21 Jul 17
Additional proxy soliciting materials
12:00am
SC 13G
7ezoyi
20 Jul 17
Peregrine Pharmaceuticals Inc
12:00am
DFAN14A
3pvb8 oknzb2
20 Jul 17
Additional proxy materials by non-management
12:00am
SC 13D/A
nsfmb2u4kkn91ctb ak
14 Jul 17
Peregrine Pharmaceuticals Inc
12:00am